Literature DB >> 12741736

Cyclosporin A therapy for steroid-dependent Henoch-Schönlein purpura.

Dan-Ching Huang1, Yao-Hsu Yang, Yu-Tsan Lin, Bor-Luen Chiang.   

Abstract

Henoch-Schönlein purpura is one of the most common types of systemic vasculitis in children. Although recurrence is frequent, most cases are benign and self-limited. Standard treatment consists of supportive care and nonsteroid antiinflammatory drugs and/or steroid. Here we report 2 cases of Henoch-Schönlein purpura, both of which had a prolonged and corticosteroid-dependent disease course. After treatment with cyclosporin A, the symptoms and signs subsided gradually in both cases with no recurrence after tapering of corticosteroid and cyclosporin A.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12741736

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

1.  Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial.

Authors:  Outi Jauhola; Jaana Ronkainen; Helena Autio-Harmainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2011-05-28       Impact factor: 3.714

2.  Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura.

Authors:  Tao Chen; Zai-Pei Guo; Yu-Hong Zhang; Ying Gao; Hong-Jie Liu; Jing-Yi Li
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 2.631

3.  Significance of antineutrophil cytoplasmic antibody in adult patients with Henoch-Schönlein purpura presenting mainly with gastrointestinal symptoms.

Authors:  Yan Zhang; Yong-Kang Wu; Matthew-A Ciorba; Qin Ouyang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

4.  Recurrent Henoch-Schönlein purpura controlled with ciclosporin.

Authors:  M J Harries; P McWhinney; R Melsom
Journal:  J R Soc Med       Date:  2004-04       Impact factor: 18.000

5.  Successful Treatment of IgA Vasculitis Complicated with Bowel Perforation and Crescentic Glomerulonephritis by Combination Therapy of Glucocorticoid, Cyclosporine and Factor XIII Replacement.

Authors:  Keiko Koshiba; Sei Muraoka; Toshihiro Nanki; Satoru Komatsumoto
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.